Phase II trial of chemoradiotherapy using weekly gemcitabine (GEM) in patients (pts) with locally advanced pancreatic cancer (PC). Final resultsChigusa Morizane, H. Ikeda, Yuta Ito et al.|Journal of Clinical Oncology|2004Cited by 0